How to Get Adderall XR in South Dakota

What Is Adderall XR and Why Does the Prescription Path Matter in South Dakota

Adderall XR contains four amphetamine salts: 75% dextroamphetamine and 25% levoamphetamine, delivered in a bi-modal bead capsule that provides roughly 12 hours of coverage. The FDA approved the original Adderall XR formulation for ADHD in children aged 6 and older and subsequently for adults. Because the DEA classifies mixed amphetamine salts as Schedule II, every step of the prescribing chain from evaluation to dispensing follows stricter rules than Schedule III to V medications. South Dakota adopts federal Schedule II restrictions in full under SDCL 34-20B, meaning no refills are permitted on a single prescription, and quantities are generally limited to a 30-day supply per fill. Understanding these rules before your first appointment saves weeks of back-and-forth with pharmacies and insurers. [1][2]

The clinical rationale for stimulant therapy in ADHD is strong. The landmark MTA Cooperative Group trial (N=579, 14-month duration) found that carefully managed medication produced significantly greater improvement in ADHD symptom scores than behavioral treatment alone, with a combined treatment arm showing the broadest benefit across comorbid anxiety and academic outcomes. [3] A 2018 Cochrane review of methylphenidate in children (N=10,068 across 190 trials) confirmed that stimulant medications produce moderate-to-large effect sizes on teacher-rated ADHD symptoms compared to placebo, a finding that generalizes to amphetamine class drugs. [4] Adderall XR's FDA label sets an approved dose ceiling of 30 mg per day for adults and children 13 and older; doses above 30 mg/day have not demonstrated added clinical benefit in controlled trials. [1]

Who Can Prescribe Adderall XR in South Dakota

Any South Dakota-licensed MD, DO, nurse practitioner (NP), or physician assistant (PA) with an active DEA registration may write a Schedule II prescription for Adderall XR. South Dakota grants NPs and PAs full prescriptive authority for controlled substances, provided they hold a valid DEA number and comply with any applicable collaborative practice or supervision agreement on file with the SD Board of Medical Examiners or SD Board of Nursing. [5] Psychiatrists, primary-care physicians, and pediatricians write the majority of ADHD stimulant prescriptions in the state, but there is no law restricting this to specialists.

Dentists and optometrists, even if licensed in South Dakota, lack the scope-of-practice authority to diagnose ADHD or prescribe stimulants. Naturopathic doctors licensed in SD do not have Schedule II prescribing authority. If you are seeing a therapist or psychologist, they may conduct standardized ADHD testing (such as the Conners' Rating Scales or TOVA), but a separate prescribing clinician must sign the controlled substance prescription. [6]

The South Dakota Board of Pharmacy maintains a public license verification database where patients can confirm that a prescriber holds an active controlled substance registration before their appointment, which prevents delays caused by lapsed DEA credentials.

How Telehealth Prescribing Works for Adderall XR in South Dakota

Telehealth prescribing of Schedule II stimulants is currently permitted in South Dakota under a DEA policy that has extended pandemic-era flexibilities. The DEA's proposed telemedicine rules, published in the Federal Register in 2023, would require at least one in-person evaluation before a clinician can prescribe Schedule II controlled substances via telehealth for new patients; however, as of mid-2025 these rules have not been finalized, and the Ryan Haight Act special registration exemption remains active. [7] South Dakota independently allows telemedicine prescribing of controlled substances when the clinician holds an active SD license and DEA registration, the patient is physically located in South Dakota at the time of the visit, and the standard of care for evaluation is met. [8]

A telehealth ADHD evaluation that meets this standard typically includes a structured clinical interview covering DSM-5 criteria (at least five of nine inattentive or hyperactive-impulsive symptoms present for 6 or more months in two settings), review of prior records, standardized rating scales, and a safety screening for cardiovascular risk and substance use history. [9] The American Academy of Pediatrics 2019 clinical practice guideline specifies that diagnosis should involve parent and teacher reports for children under 12, a requirement that telehealth platforms must still satisfy even when the visit is remote. [10]

After the evaluation, the prescriber sends a Schedule II electronic prescription (EPCS) directly to the patient's chosen South Dakota pharmacy. South Dakota adopted EPCS for controlled substances under SD House Bill 1076 (2020), making paper prescriptions optional but still legally acceptable. Most telehealth platforms complete EPCS transmission on the day of the visit. [11]

Step-by-Step Process to Get Your First Adderall XR Prescription in South Dakota

Getting from evaluation to first fill involves six discrete steps, each with its own timeline.

Step 1: Choose a prescriber or telehealth platform. Select a South Dakota-licensed clinician or a telehealth service that confirms its prescribers hold active SD DEA registrations. Verify this on the DEA Diversion Control Division's online lookup before booking. [7]

Step 2: Complete pre-visit intake. Most platforms request prior medical records, any existing neuropsychological testing, and a completed ADHD rating scale (Adult ADHD Self-Report Scale or Vanderbilt for children). Gathering these before the appointment shortens the visit and improves diagnostic accuracy. [9]

Step 3: Attend the evaluation visit. The clinician applies DSM-5 criteria, reviews cardiovascular history, checks blood pressure, and screens for contraindications including structural cardiac abnormalities, hyperthyroidism, glaucoma, and prior stimulant-induced psychosis. Baseline blood pressure and heart rate are standard. [1]

Step 4: Receive the prescription. For a new ADHD diagnosis, most prescribers start at 10 mg or 20 mg once daily for adults and 5 mg to 10 mg for children aged 6 to 12. The prescription is transmitted to your pharmacy via EPCS or a signed paper Rx. No fax transmission is allowed for Schedule II in South Dakota without specific pharmacy-acknowledged circumstances. [2]

Step 5: Insurance and prior authorization. Many South Dakota commercial plans require prior authorization (PA) for brand-name Adderall XR. The PA packet typically needs DSM-5 diagnosis documentation, failure of one generic trial, and a letter of medical necessity. PA review takes 1 to 5 business days. [12] Generic mixed amphetamine salts ER often bypass PA entirely and cost $30 to $60 per month without insurance. [13]

Step 6: Pharmacy fill. Present a government-issued ID at the pharmacy counter. Some South Dakota pharmacies, particularly in rural counties, may have limited Schedule II stock; calling ahead confirms availability. Most major chains in Sioux Falls, Rapid City, and Aberdeen maintain consistent stock.

What Labs or Tests Are Required Before Starting Adderall XR

No single mandatory lab panel is required by South Dakota law before prescribing Adderall XR, but evidence-based clinical practice includes several baseline assessments. The American Heart Association's 2008 scientific statement recommended routine electrocardiogram (ECG) screening before stimulant initiation, though this was subsequently moderated by the AAP, which noted that ECG is not mandatory unless a personal or family history of cardiac disease exists. [14] A 2023 JAMA Pediatrics meta-analysis (N=1,102,507 children across 8 cohort studies) found no statistically significant increase in serious cardiovascular events in children taking stimulants versus controls, though absolute event rates were low enough that caution still applies in high-risk patients. [15]

Routine clinical assessments before starting Adderall XR include:

• Blood pressure and heart rate measurement (required at every visit per FDA label) [1]
• Height and weight in children (stimulants may suppress appetite and slow growth velocity by roughly 1 cm/year over 3 years, per MTA follow-up data) [16]
• Screening for personal or family history of sudden cardiac death, arrhythmia, or structural heart defect
• Screening for bipolar disorder, psychosis, or active substance use disorder (stimulants are contraindicated in untreated bipolar I and may precipitate psychosis in predisposed individuals) [1]
• Thyroid function testing if hyperthyroid symptoms are present, since hyperthyroidism mimics ADHD and also contraindicates stimulant use

A full metabolic panel or complete blood count is not standard practice for otherwise healthy ADHD patients and is not required by any current South Dakota or national guideline. [10]

Prior Authorization Requirements in South Dakota

South Dakota commercial insurers and employer-sponsored plans vary widely in their PA criteria for Adderall XR, but a common template exists across most plans.

A typical South Dakota PA submission for brand-name Adderall XR includes:

1. DSM-5 diagnosis code (F90.0 inattentive, F90.1 hyperactive-impulsive, or F90.2 combined presentation) with documentation of symptom duration of at least 6 months and impairment in two settings. [9]
2. Step-therapy attestation. Most plans require a documented trial of generic mixed amphetamine salts ER at an adequate dose (typically 20 mg/day for adults for at least 30 days) with documented inadequate response or intolerance before approving the brand.
3. Letter of medical necessity from the prescribing clinician, including the clinical rationale for brand over generic (for example, bead-dose delivery differences or a documented adverse reaction to a specific generic's inactive ingredients).
4. Age-appropriate rating scale results. Many plans request Conners' 3, Vanderbilt, or Adult ADHD Self-Report Scale (ASRS v1.1) scores showing clinically significant impairment. [6]

South Dakota Medicaid (Wellmark SD and Sanford Health Plan Medicaid) does not cover Adderall XR for ADHD or narcolepsy as of 2025, meaning Medicaid-enrolled patients must pay out of pocket or use manufacturer savings programs. Takeda and generic manufacturers offer discount programs; GoodRx pricing for 30 capsules of generic mixed amphetamine salts ER 20 mg in Sioux Falls ranges from approximately $28 to $55 depending on pharmacy. [13]

Appeals for PA denials in South Dakota are governed by SD Administrative Rule 20:06:14, which gives insurers 30 days to respond to a standard appeal and 72 hours for an urgent clinical appeal. [12]

Transferring an Adderall XR Prescription to South Dakota

Federal law is unambiguous here. Schedule II prescriptions cannot be transferred between pharmacies. The DEA's 21 CFR 1306.25 explicitly excludes Schedule II drugs from the transfer rules that apply to Schedule III to V substances. [7] If you are relocating to South Dakota from another state, you must obtain a new prescription from a South Dakota-licensed prescriber. Your previous out-of-state prescriber can share medical records and a treatment summary to support continuity, but the physical or electronic Rx itself cannot be redirected or transferred to a South Dakota pharmacy.

Practically, this means: schedule a new-patient appointment with a South Dakota clinician or telehealth provider before your move, or within the first 30 days of arriving. Bring documentation of your prior ADHD diagnosis, neuropsychological testing if available, and the name and dose of your current medication. Most clinicians treating established ADHD patients with documented prior response will continue an existing regimen rather than restart from a low titration dose, reducing the re-stabilization period. [3]

503A Compounding Pharmacies and Amphetamine Salts in South Dakota

Licensed 503A compounding pharmacies in South Dakota may prepare patient-specific amphetamine salt formulations when a commercial product does not meet a patient's clinical need. Common reasons include dye allergies to FD&C Blue No. 1 (present in some Adderall XR capsules), specific dose strengths not available commercially, or swallowing difficulties requiring a liquid suspension. [17] The FDA's guidance on compounding of controlled substances specifies that 503A pharmacies must operate under a valid DEA registration for Schedule II compounding, must compound only on receipt of a valid patient-specific prescription, and may not compound in advance for office stock. [18]

South Dakota pharmacies operating under a 503A designation are inspected by the SD Board of Pharmacy and must comply with USP Chapter 795 (non-sterile compounding) standards. Turnaround time for a compounded amphetamine preparation typically runs 3 to 7 business days after receipt of the prescription. Costs are generally not covered by insurance and range from $60 to $150 per 30-day supply depending on formulation complexity. [13]

Patients considering a compounded formulation should ask their prescriber to note the specific clinical justification on the prescription, since pharmacies are required to retain this documentation under DEA record-keeping rules. [18]

Finding an In-Person ADHD Prescriber in South Dakota

South Dakota has fewer than 25 practicing psychiatrists per 100,000 residents, a ratio that places it among the lowest in the country for specialist access. [19] Primary-care physicians and NPs shoulder the majority of ADHD stimulant prescribing in the state, particularly west of the Missouri River. Wait times for a new-patient psychiatric appointment in Rapid City or Pierre may exceed 90 days; telehealth platforms typically offer evaluations within 2 to 14 days.

The South Dakota Psychological Association and the SD Medical Association both maintain referral directories searchable by county. For pediatric ADHD, Sanford Health in Sioux Falls and Monument Health in Rapid City operate dedicated pediatric behavioral health programs that accept self-referrals. [20]

Rural patients in tribal areas served by Indian Health Service facilities should know that IHS providers may prescribe Schedule II medications through IHS pharmacies, which stock common stimulants and operate under DEA institutional registration rather than individual provider registration.

Monitoring After Starting Adderall XR in South Dakota

The FDA label for Adderall XR requires blood pressure and heart rate monitoring at every visit after initiation. [1] The standard follow-up cadence in South Dakota clinical practice mirrors national recommendations: a 2 to 4 week check-in after starting or changing the dose, then every 3 months for the first year, and every 6 months once the dose is stable. [10] South Dakota Schedule II prescribing law limits each Rx to a 30-day supply with no refills, which creates a built-in monthly touchpoint between prescriber and patient.

Growth should be plotted at every pediatric visit. Children who lose more than 1 standard deviation in height or weight percentile over 12 months may need a drug holiday evaluation or dose reduction. [16] Adults should report any new chest pain, palpitations, or shortness of breath promptly, given that amphetamines increase heart rate by an average of 3 to 6 bpm and systolic blood pressure by 2 to 4 mmHg at therapeutic doses per the FDA label. [1]

The 2019 AAP clinical practice guideline states: "For children 6 years and older, FDA-approved medications for ADHD should be prescribed, along with parent- and/or teacher-administered behavior therapy as treatment for ADHD, preferably both." [10] This combination approach remains the standard of care regardless of whether the initial evaluation occurs in person or via telehealth.